Four Federal Efforts to Monitor, Including RESULTS Act Progress
Other proposals aim to increase fraud enforcement, temper prior authorization, and modernize CLIA
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
Other proposals aim to increase fraud enforcement, temper prior authorization, and modernize CLIA
The legal strategy of the ACLA—and some political luck—prevailed in the lawsuit against LDT oversight
Two OIG advisory opinions guide laboratories that want to work with pharma or medical device companies on expanded testing
The majority of Labcorp’s revenue growth in the first quarter came from clinical lab acquisitions
Clinical lab billing teams face an overwhelming number of challenges if revenue cycle strategies fall short
Labcorp will acquire oncology-related clinical tests services from BioReference’s parent company, OPKO Health
Read this overview of legislation and regulations governing laboratory marketing practices and learn tips to ensure these activities remain compliant
As of March 1, 2026, CMS will move CLIA away from paper-based transactions to improve efficiency and payments
The board was eliminated as part of a sweeping reordering of the Department of Health and Human Services
A leaked budget document for the next fiscal year suggested non-user fee funding may be up slightly compared to recent years.
The role at this point is theoretical, but our editors asked AI for help in drafting what the position might entail